Status:
COMPLETED
Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease
Lead Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Conditions:
Chronic Kidney Disease Due to Hypertension
Chronic Kidney Disease Due to Type 2 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
What the investigators want to achieve with the protocol is to identify the impact of intestinal microbiota transplantation on the progression of chronic kidney disease. Hypothesis: Modification of i...
Detailed Description
What the investigators want to achieve with the protocol is to identify that impact has transplantation intestinal microbiota on the progression of chronic kidney disease A.-Hypothesis: Modification ...
Eligibility Criteria
Inclusion
- Be diagnosed with CKD and creatinine clearance less than 60 ml / minute secondary to hypertension and / or diabetes.
- Age over 18 years
Exclusion
- Malignant neoplasms whose last treatment was less than 5 years
- Having received antibiotics for any reason during the month prior to enrollment
- Have received probiotics in the last 3 months
- Have been diagnosed with Clostridium difficile infection in the last year
- Have been previously submitted to TMF
- Having presented ERC exacerbations during the 3 months prior or present at the time of enrollment
Key Trial Info
Start Date :
August 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 21 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04361097
Start Date
August 7 2018
End Date
April 21 2020
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario José E. Gonzalez
Monterrey, Nuevo León, Mexico, 64460